About GlucoTrack Inc
- Industry: Health Care
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://glucotrack.com/
Frequently Asked Questions
What is the 52-week range for GCTK?
The 52-week high is $136.29 and the 52-week low is $1.38005.
What is the P/E ratio for GCTK?
The P/E ratio data is currently unavailable.
What is the dividend yield for GCTK?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -393.33%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -3871.60%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 1.25.
Latest GCTK News
Lōkahi Therapeutics™ Expands University of Georgia Collaboration Through First International ai² Pipeline™ Project with Universität Paderborn
RUTHERFORD, N.J. & LA JOLLA, Calif., October 01, 2026--Lōkahi expands its UGA collaboration internationally with Universität Paderborn, increasing ai² platform capacity and strategic revenue opportunities.
Lōkahi Therapeutics™ Announces Qare™, the First Real-Time Comparative Health Platform for GLP-1 Medications, with Public Availability Beginning October 14
RUTHERFORD, N.J. & LA JOLLA, Calif., September 30, 2026--Lōkahi Therapeutics™ announces Qare™, a new comparative health platform for GLP-1 users, available beginning October 14, 2026.
Glucotrack’s Subsidiary Lōkahi Therapeutics Unveils Qare Comparative Health Platform For GLP-1 And Other Treatment Outcomes
Developed Through ai² Accelerator™, Qare™ Is Designed to Enable Users to Compare Their Experiences Against Cohorts of People Like Them, with Additional Drug Classes Expected to FollowLōkahi Therapeutics™, a subsidiary
Top movers in Friday's session
Curious to know what's happening on the US markets one hour before the close of the markets on Friday? Join us as we explore the top gainers and losers in today's session.
Top movers analysis in the middle of the day on 2026-09-25: top gainers and losers in today's session.
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Firefly Neuroscience (NASDAQ:AIFF) shares increased by 33.2% to $1.58 during Friday's regular session. The company's market cap stands at $18.6 million. Apimeds Pharmaceuticals (AMEX:APUS) shares moved
Lōkahi Therapeutics™ Expands ai2 Pipeline™ Program Through Collaboration with Pepperdine E2B™
RUTHERFORD, N.J. & LA JOLLA, Calif., September 25, 2026--Lōkahi Therapeutics™ partners with Pepperdine E2B™ to expand ai² Pipeline™, engaging MBA students in evaluating biopharmaceutical assets.
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Apimeds Pharmaceuticals (AMEX:APUS) shares rose 23.4% to $6.07 during Friday's pre-market session. The market value of their outstanding shares is at $7.4 million. Firefly Neuroscience (NASDAQ:AIFF) shares
Unusual volume stocks in Thursday's session
Unusual volume stocks in Thursday's session
Which stocks are moving on Thursday?
Wondering how the US markets performed in the middle of the day on Thursday? Discover the movers and shakers of today's session in our comprehensive analysis.
The market is filled with gapping stocks in Thursday's session.
The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Apimeds Pharmaceuticals (AMEX:APUS) shares increased by 162.4% to $6.01 during Thursday's regular session. The market value of their outstanding shares is at $3.4 million. Surrozen (NASDAQ:SRZN) stock
Glucotrack, Inc. Announces Pricing of $3 Million Public Offering
RUTHERFORD, N.J. & LA JOLLA, Calif., September 24, 2026--Glucotrack, Inc. Announces Pricing of $3 Million Public Offering.
Wondering what's happening in today's pre-market session?
As the US market prepares to open on Thursday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
What's Going On With GlucoTrack Shares On Thursday?
GlucoTrack subsidiary Lokahi Therapeutics secured its first external fee-for-service partnership with nonprofit Innovate GBM for glioblastoma research.
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Profusa (NASDAQ:PFSA) stock increased by 112.5% to $4.36 during Thursday's pre-market session. The company's market cap stands at $1.2 million. GlucoTrack (NASDAQ:GCTK) stock rose 96.55% to $3.99. The
Why GlucoTrack Shares Are Trading Higher By Around 118%; Here Are 20 Stocks Moving Premarket
GlucoTrack surged 117.7% premarket after Lokahi Therapeutics signed its first external partnership; other stocks saw notable gains and losses.
Glucotrack Stock Is Trending: Here's Why GCTK Jumped Over 80% After Hours
GlucoTrack shares soar 80% after-hours as Lokahi Therapeutics signs first external glioblastoma licensing partnership with Innovate GBM.
Stay updated with the stocks that are on the move in today's after-hours session.
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Lōkahi Therapeutics™ Advances its Proprietary ai² PIPELINE (formerly ai² Futures Lab) Process from Internal Asset Engine to Revenue-Generating Platform
RUTHERFORD, N.J. & LA JOLLA, Calif. & LOS ANGELES, September 23, 2026--Lōkahi Therapeutics™ Advances its Proprietary ai² PIPELINE Process from Internal Asset Engine to Revenue-Generating Platform.
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers GlucoTrack (NASDAQ:GCTK) stock moved upwards by 90.6% to $3.87 during Wednesday's after-market session. The market value of their outstanding shares is at $1.7 million. Greenland Mines (NASDAQ:GRML) shares
Glucotrack Subsidiary Lōkahi Therapeutics Engaged Two ai² PIPELINE Project Teams To Identify And Evaluate Brain Tumor Therapeutic Assets Available For Licensing And Development
Innovate GBM becomes the first external organization to engage the ai² Division on a fee-for-service basis to identify brain tumor therapeutic assets for potential licensing and developmentLōkahi Therapeutics™ Inc., a
Lōkahi Therapeutics™ and Glucotrack CEO Erik Emerson Provides Strategic Update on LT-100, ai² Platform Growth and Clinical Development Priorities
RUTHERFORD, N.J. & LA JOLLA, Calif., September 23, 2026--Lōkahi CEO Erik Emerson outlines LT-100 progress, ai² platform growth, and a strategy to discover, advance, and monetize assets.
Lōkahi Therapeutics And Glucotrack Issue Update On LT-100 Program And ai² Asset Monetization Strategy
Lōkahi Therapeutics™ today issued a strategic corporate update highlighting progress in its LT-100 development program, expansion of its ai² platform, and priorities for advancing and monetizing differentiated
Lōkahi Therapeutics™ Continues ai² Pipeline™ Division Collaboration with The University of Alabama to Advance Asset Evaluation and Biopharma Talent
RUTHERFORD, N.J. & LA JOLLA, Calif., September 18, 2026--Lōkahi Therapeutics™ renews its University of Alabama collaboration, advancing real-world asset evaluation and developing key future biopharma talent.
Glucotrack’s Lōkahi Therapeutics Announces University Of Alabama’s Culverhouse College Of Business Will Continue Its Participation In ai² Pipeline Division For Upcoming Academic Year
Lōkahi Therapeutics™, a subsidiary of Glucotrack, Inc. (NASDAQ:GCTK), today announced that The University of Alabama’s Culverhouse College of Business will continue its participation in the ai² Pipeline division for the
Let's have a look at the top gainers and losers in the middle of the day of today's session.
Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top gainers and losers in today's session.
Traders are paying attention to the gapping stocks in Friday's session.
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Friday.
Glucotrack Announces $11.5 Million Financing
RUTHERFORD, N.J. & LA JOLLA, Calif., September 11, 2026--Glucotrack announces $11.5M convertible note financing, including new capital and note rollover, to support strategic growth.
Glucotrack Secures $11.5M Convertible Note Financing
Glucotrack, Inc. (NASDAQ:GCTK) ("Glucotrack" or the "Company") today announced definitive agreements for convertible notes with an aggregate principal amount of approximately $11.5 million, including
Lōkahi Therapeutics™ Expands ai² Into Three Opportunity-Creating Business Divisions
RUTHERFORD, N.J., & LA JOLLA, Calif., September 08, 2026--Lōkahi Therapeutics™ launches three ai² divisions to potentially drive revenue, expand partnerships, develop talent, and accelerate innovation.
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers iSpecimen (NASDAQ:ISPC) shares increased by 10.4% to $1.7 during Friday's after-market session. The market value of their outstanding shares is at $3.8 million. Genelux (NASDAQ:GNLX) stock moved upwards by
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2025-10-03 | Carter Erin Catherine | +4,055 | - | - |
| 2025-10-03 | Carter Erin Catherine | +386 | - | - |
| 2025-10-03 | Malave Luis | +4,055 | - | - |
| 2025-10-03 | Malave Luis | +463 | - | - |
| 2025-10-03 | Balo Andrew K | +4,055 | - | - |
| 2025-10-03 | Balo Andrew K | +1,285 | - | - |